Password-protected portal for OBI client companies’ use.
AirOmatix is developing the only portable oxygen concentrator for high-flow oxygen patients, freeing them from bulky oxygen cylinders. Our novel, patent-pending technology will also enable us to develop low-flow oxygen concentrators that are smaller and quieter than existing options.
CANX LLC is developing therapeutics to address iron related health conditions such as iron overload disease and certain forms of cancer which depend on iron for their growth.
Caravel is a catalysis company for the 21st century and beyond. We make the chemicals the world depends on from truly sustainable carbon sources. We do this through innovative biotechnologies that make sustainable catalysis achievable at scale.
Circumvent Pharmaceuticals is a drug discovery and development company focused on the high, unmet need of Batten patients.
EndoSound is developing an after-market ultrasound imaging system for use with a conventional (optical) endoscope, enabling a GI physician to perform Endoscopic Ultrasound (EUS) in addition to conventional endoscopy with the same basic scope.
ESG Brands is a sustainable technology company operating in the materials science space with agricultural waste as feedstock. ESG Brands core technology is a green chemistry based degumming process for the textile industry–clothing and footwear, home textiles, and technical textiles–converting agricultural waste into cotton 10x faster than conventional processes with potable water as a byproduct. In addition, the company is active in sustainable manufacturing and the broader materials science space: food and beverage, and next-gen bio-synthetics. ESG Brands believe that Environmental, Social, and Governance (ESG) is essential for a sustainable future, and are committed to using business to make a positive impact on the planet. The first materials product from ESG will be marketed as BANEX, the world’s next natural fiber, from the daily waste streams at banana plantations.
Gamma Diagnostics is an early stage biotechnology company developing novel medical devices for cardiovascular risk assessment, surgical therapy and hemorrhage control based upon the use of human clotting proteins.
GenerX is a privately owned pharmaceutical company focused on the development and commercialization of complex sterile injectable generic drug products for the U.S. and overseas markets. Founded in 2020, GenerX’s leadership team has over 100 years of combined experience in the pharmaceutical industry and has developed and commercialized over 30 injectable drug products.
Health Technology Innovations (HTI) is a Portland based startup company developing advanced medical image processing solutions using artificial intelligence and machine learning. Founded in 2017 by former Intel engineers, HTI is partnering with the Oregon Health and Science University’s National Cryo-EM Research Center to improve processing and analysis of large imaging datasets using cryogenic electron microscopy (cryo-EM), the Nobel Prize-winning imaging method that is revolutionizing structural biology.
Hemex Health is developing affordable, accurate tests for millions of people who are at risk for malaria and sickle cell disease and who lack access to viable diagnostics. The one minute, $1 Hemex malaria test is 10x to 20x more accurate than the current technology used in routine testing. Hemex’s portable solutions are designed to provide benefit quickly and effectively for healthcare workers and patients, whether in a modern clinic or remote corner of the world.
Keliomics offers pharmacophenotyping for patients with solid tumors including breast, prostate, and certain types of metastatic cancer.
Madorra is developing the first non-hormonal, non-invasive medical device to treat vaginal dryness and atrophy. Madorra’s simple, easy-to-use device will empower the millions of breast cancer survivors and post-menopausal women suffering from vaginal dryness to improve their sexual health and return to wellness.
NeuvaRx is preclinical-stage biopharmaceutical company dedicated to the development of therapies and diagnostic tools for neurovascular disorders, including, but not limited to ischemic and hemorrhagic stroke and vascular dementia.
The OmnEcoil is a novel device that utilizes the benefits of MRI for prostate cancer detection and tissue sampling in one integrated procedure for a more efficient and accurate diagnosis.
PDX Pharmaceuticals is a biopharmaceutical company leveraging novel nanotechnology and cancer systems biology to develop next-generation combination immunotherapies for cancer.
ProMedix Inc is a medical device company aiming to develop technology to simplify diagnostic home healthcare as well as ER/Critical Care. The current product under development is a platform technology that aides in the diagnostic evaluation as well as monitoring of therapeutic interventions of multiple medical conditions including trauma, dehydration and sepsis.
Qtonics LLC was formed to help companies, private research institutes and academic institutions accelerate scientific discovery. Our growing portfolio includes recombinant proteins, antibodies and immunology-based detection kits used in cancer, cell growth and other immunology-based studies. We understand the needs of the academic research laboratory through to the regulatory requirements of cGMP research and manufacturing facilities.
Refeyn produces a disruptive new generation of analytical instruments that measure the mass of individual molecules directly in solution. Mass photometry offers an easy and universal way to characterize the structure, dynamics and function of biomolecules, accelerating research and drug discovery.
Rewire AI offers artificial intelligence services for biomedical image analysis in clinical, veterinary and research applications. Rewire’s machine learning platform, Sightologist.ai, provides computer vision integration as a service to 3rd party devices and software for automation and standardization of biomedical image analysis. The Sightologist.ai engine also powers Rewire’s consumer-facing analysis software, called Pipsqueak AI, which is used by thousands of researchers around the world to quantify tissue samples.
RxHomeTest is an at-home health test provider that provides reliable, convenient, and confidential lab tests to anyone seeking to check, monitor, and prevent health issues.
Senju Pharmaceutical develops health care products for the ears, eyes, nose, skin and throat. For nearly three decades, Senju has developed ophthalmological products, recently diversifying into other areas that ensure the healthy functioning of our senses. Senju collaborates with international research initiatives, academic institutions and researchers, and industry specialists to unlock medical secrets that lead to pharmaceutical breakthroughs.
Sirona Dx accelerates the pace of targeted-therapy development to improve outcomes for cancer patients. Sirona is a technology-agnostic CRO that offers specialized high complexity genomics services supporting pharmaceutical companies with their drug discovery and development programs.
Sonivate Medical (SMI) develops and markets innovative ultrasound technology. The company’s technology opens new markets for ultrasound by extending its use into new classes of procedures and new clinical settings. The SonicEye, SMI’s first product, is a fingertip-mounted ultrasound probe that combines ultrasound imaging with simultaneous tactile feedback, while leaving both hands free to do work. 2012 BVC, 2013 WAC launch company winners. Sonivate received FDA clearance in February 2020 to market SonicEye Dual-Array Ultrasound System. The product is expected to begin rollout the summer of 2020.
StoneStable, Inc. has developed nano-technology to protect vaccines from spoilage and allows transportation and distribution at ambient temperature, eliminating the “cold-chain”. Every year 1.5 million children die from vaccine preventable diseases, many because they do not have access to vaccines. Moreover, up to 50% of vaccines, a $25 billion industry, are wasted due to problems with refrigerated transportation and storage. StoneStable, Inc. solves these problems. In addition StoneStable Inc’s technology enhances vaccine function allowing lower dosage.
SUTUREGARD Medical Inc. is an innovation company creating medical device solutions to solve surgical problems and improve outcomes. Our FDA registered devices manage the #1 unsolved problem in wound closure: high suture tension. High tension can damage tissue and lead to wound complications in at-risk surgical wounds. With HEMIGARD®ARS and SUTUREGARD®ISR tension reducing devices, many more wounds can be successfully closed that would have otherwise been left open to heal on their own, or required flaps or skin grafts. More at www.suturegard.com.
Thaena Inc. is a women-led early stage biotech company. Our mission is to reduce suffering by restoring balance to the microbial ecosystems.
At Thaena we achieve our mission through research and development of all natural pre and postbiotic products derived containing hundreds of compounds and metabolites that work together to balance and restore native microbial ecosystems. Our main focus is to produce and manufacture effective, safe, and reproducible (cGMP) products that are scientifically proven to support health via the microbial ecosystems of the gut and/or skin.
Thaena’s vision is to be the leading and trusted manufacturer and supplier of naturally derived pre and postbiotic active ingredient products. We are working towards this goal with a data-driven approach researching the molecules (postbiotics) that are found in healthy human stool. This work is based on the pioneering work of our founders in Fecal Microbiota Transplant as well as an experienced research team. We are pioneers in advancing our understanding of microbiome science by providing a research and development platform that will allow for exploration and discovery of what it means to be “healthy” from the lens of the microbes.
A new roadmap to surgery
Trace Biosciences is creating targeted imaging agents that highlight nerves in real time for surgery.
Established in 2020, Vaginal Biome Science is a biotechnology company that develops vaginal microbiota-based therapies to protect and restore microbial health. The vaginal microbiome plays host to a complex microbial community which has a profound impact on women’s health and wellbeing. Modulation of the vaginal microbiome can radically improve disease prevention and treatment, giving women more agency over their vaginal health and wellness.
Established in 2012, Veana Therapeutics, Inc., is a privately held Oregon-based biotechnology company whose business strategy is to identify Alpha-TEA-based cancer immunotherapy technologies.
Alpha-TEA immunotherapy technologies are based on orally bioavailable anti-cancer agents that simultaneously kill tumor cells and stimulate the immune system. Alpha TEA platform products can be combined with other forms of immunotherapy to further improve anti-tumor activity.
Velanidi Technologies is a research and development company focused on creating therapeutics that bridge biology and microelectronics.
VBD advances diagnostic and therapeutic research from top universities and companies towards commercial products. Projects include blood based diagnostics for aneurysm and a therapeutic protein for multiple sclerosis, stroke, traumatic brain injury and methamphetamine use disorder.
VitalFlo helps leading clinicians and researchers improve patient outcomes and advance lung health by providing comprehensive respiratory data, analysis and care.
Vivifi Medical is developing a permanent solution that reverses Benign Prostate
Hyperplasia (BPH) through a robotic/laparoscopic procedure.